AI assistant
Pulmonx Corp — Director's Dealing 2025
Mar 6, 2025
34428_dirs_2025-03-05_5252a53a-ab6b-477b-8e9b-7ec7986e3117.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Pulmonx Corp (LUNG)
CIK: 0001127537
Period of Report: 2025-03-03
Reporting Person: Lehman David Aaron (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-03-03 | Common Stock | S | 669 | $7.14 | Disposed | 197182 | Direct |
| 2025-03-03 | Common Stock | S | 1177 | $7.14 | Disposed | 196005 | Direct |
| 2025-03-03 | Common Stock | S | 4490 | $7.14 | Disposed | 191515 | Direct |
| 2025-03-03 | Common Stock | S | 2397 | $7.14 | Disposed | 189118 | Direct |
| 2025-03-03 | Common Stock | S | 13622 | $7.97 | Disposed | 175496 | Direct |
| 2025-03-03 | Common Stock | A | 108000 | — | Acquired | 283496 | Direct |
Footnotes
F1: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on June 1, 2021.
F2: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2022.
F3: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023.
F4: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2024.
F5: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2024.
F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.88 to $8.23, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F7: Represents grant of RSUs payable solely in common stock of the Issuer that vest in equal quarterly installments over the four-year period from the grant date of March 3, 2025.